Clinical Trial Update: NO AD: Use of Nitric Oxide (NO) Donors for the Prevention of Autonomic Dysreflexia (AD) During Bowel Care Following SCI [Phase 2]

View source ↗

Summary

This document describes a Phase 2 clinical trial assessing nitric oxide donors to prevent autonomic dysreflexia during bowel care in individuals with spinal cor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autonomic Dysreflexia
• Spinal Cord Injury

Drugs mentioned

• Nitric Oxide donors (nitric oxide donor(s))

Snippet

Sponsor: Simon Fraser University | Conditions: Spinal Cord Injuries, Autonomic Dysreflexia | Phase 2 | Status: NOT_YET_RECRUITING